Will the AACR Annual Meeting 2026 opening session on April 17, 2026 feature a publicly announced clinical trial result for a cancer immunotherapy with a sample size of at least 500 patients, as confirmed by an official AACR press release?

AACR publishes a press release on or before April 18, 2026 announcing a randomized or single-arm clinical trial result presented at the meeting with at least 500 enrolled patients where the primary intervention is an immunotherapy agent Source: AACR official meeting press releases at aacr.org/meeting/aacr-annual-meeting-2026/